CETROTIDE Side Effects

7006972-3 | Ovarian Hyperstimulation Syndrome
on Sep 09, 2010 Female patient from FRANCE , weighting 138.9 lb, was diagnosed with polycystic ovaries and was treated with Cetrotide (View Usage). Patient experienced the following unwanted or unexpected effects: ovarian hyperstimulation syndrome. Cetrotide dosage: . During the same period patient was treated with GONAL F (View Gonal-f Review and Gonal-f Label ), OVITRELLE (View Ovitrelle Review and Ovitrelle Label ). Patient was hospitalized.

6984408-6 | Ovarian Hyperstimulation Syndrome
Patient was taking Cetrotide (View Usage). Patient had the following side effects: ovarian hyperstimulation syndrome on Sep 09, 2010 from FRANCE Additional patient health information: Female patient , weighting 138.9 lb, was diagnosed with polycystic ovaries and. Cetrotide dosage: . During the same period patient was treated with GONAL F (View Gonal-f Review and Gonal-f Label ), OVITRELLE (View Ovitrelle Review and Ovitrelle Label ). Patient was hospitalized.

6692002-X | Hypotension, Nausea
Adverse event was reported on Feb 09, 2010 by a Female patient taking Cetrotide (View Usage) (Dosage: 1, 1 In 1 D, Subcutaneous) was diagnosed with ovarian hyperstimulation syndrome and. Location: PORTUGAL , 29 years of age, weighting 165.3 lb, After Cetrotide was administered, patient had the following side effects: hypotension, nausea (What is nausea?). During the same period patient was treated with GONAL F (300 Iu, 1 In 1 D, Subcutaneous) (View Gonal-f Review and Gonal-f Label ), MENOPUR (View Menopur Review and Menopur Label ).

6669718-4 | Amnesia, Anaphylactic Shock, Fall, Gaze Palsy, Immediate Post-injection Reaction, Syncope, Urinary Incontinence
on Mar 19, 2010 Female patient from TURKEY , 30 years of age, weighting 163.1 lb, was diagnosed with infertility (What is infertility?) and was treated with Cetrotide (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, anaphylactic shock, fall (What is fall?), gaze palsy, immediate post-injection reaction, syncope, urinary incontinence (What is urinary incontinence?). Cetrotide dosage: Once, Subcutaneous. During the same period patient was treated with GONAL F (View Gonal-f Review and Gonal-f Label ).


6662583-0 | Anaphylactic Shock, Incontinence, Syncope
on Mar 18, 2010 Female patient from TURKEY , 30 years of age, weighting 143.3 lb, was diagnosed with infertility (What is infertility?) and was treated with Cetrotide (View Usage). Patient had the following side effects: anaphylactic shock, incontinence, syncope. Cetrotide dosage: Once, Subcutaneous. During the same period patient was treated with GONAL F (View Gonal-f Review and Gonal-f Label ).

6604986-6 | Dizziness, Hypoaesthesia, Palpitations
Patient was taking Cetrotide (View Usage). After Cetrotide was administered, patient had the following side effects: dizziness (What is dizziness?), hypoaesthesia, palpitations on Feb 10, 2010 from RUSSIAN FEDERATION Additional patient health information: Female patient , 35 years of age, weighting 132.3 lb, was diagnosed with ovulation induction and. Cetrotide dosage: 0.25 Mg, 1 In 1 Days, Subcutaneous. During the same period patient was treated with MENOPUR (View Menopur Review and Menopur Label ).

6592846-9 | Hypotension, Nausea
Adverse event was reported on Jan 12, 2010 by a Female patient taking Cetrotide (View Usage) (Dosage: ) . Location: PORTUGAL , 38 years of age, Patient experienced the following unwanted or unexpected effects: hypotension, nausea (What is nausea?).

6491752-8 | Abortion Induced, Pain
on Nov 20, 2009 Female patient from TAIWAN, PROVINCE OF CHINA , 32 years of age, weighting 105.8 lb, was diagnosed with infertility (What is infertility?) and was treated with Cetrotide (View Usage). Patient had the following side effects: abortion induced, pain (What is pain?). Cetrotide dosage: 0.25 Mg, 1 In 1 Days, Subcutaneous. During the same period patient was treated with GONAL F (300 Iu, 1 Iu 1 Days, Subcutaneous) (View Gonal-f Review and Gonal-f Label ). Patient was hospitalized.

6481164-5 | Abortion Induced, Cardiac Valve Disease, Foetal Cardiac Disorder, Pain
on Nov 20, 2009 Female patient from TAIWAN, PROVINCE OF CHINA , 32 years of age, weighting 105.8 lb, was diagnosed with infertility (What is infertility?) and was treated with Cetrotide (View Usage). After Cetrotide was administered, patient had the following side effects: abortion induced, cardiac valve disease, foetal cardiac disorder, pain (What is pain?). Cetrotide dosage: 0.75 Mg, 1 In 1 Days, Subcutaneous. During the same period patient was treated with GONAL F (300 Iu, 1 In 1 Days, Subcutaneous) (View Gonal-f Review and Gonal-f Label ). Patient was hospitalized.

6478191-0 |
Patient was taking Cetrotide (View Usage). on Nov 19, 2009 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Female patient , 37 years of age, weighting 130.1 lb, was diagnosed with infertility (What is infertility?) and. Cetrotide dosage: 0.25 Mg, 1 In 1 Days, Subcutaneous. During the same period patient was treated with GONAL F (300 Iu, 1 In 1 Days, Subcutaneous) (View Gonal-f Review and Gonal-f Label ).

6478182-X | Abortion Spontaneous, Pain
Adverse event was reported on Nov 19, 2009 by a Female patient taking Cetrotide (View Usage) (Dosage: 0.25 Mg, 1 In 1 Days, Subcutaneous) was diagnosed with infertility (What is infertility?) and. Location: TAIWAN, PROVINCE OF CHINA , 39 years of age, weighting 132.3 lb, Patient had the following side effects: abortion spontaneous, pain (What is pain?). During the same period patient was treated with GONAL F (450 Iu, 1 In 1 Days, Subcutaneous) (View Gonal-f Review and Gonal-f Label ).

6427978-9 | Abortion Threatened, Fall, Vaginal Haemorrhage
on Oct 19, 2009 Female patient from TAIWAN, PROVINCE OF CHINA , 33 years of age, weighting 119.0 lb, was diagnosed with infertility (What is infertility?) and was treated with Cetrotide (View Usage). After Cetrotide was administered, patient had the following side effects: abortion threatened, fall (What is fall?), vaginal haemorrhage. Cetrotide dosage: 0.25 Mg, 1 In 1 Days, Subcutaneous. During the same period patient was treated with GONAL F (225 Iu, 1 In 1 Days, Subcutaneous) (View Gonal-f Review and Gonal-f Label ).

6406611-6 | Heart Rate Increased, Hypertension
on Sep 29, 2009 Female patient from SWITZERLAND , 37 years of age, was diagnosed with infertility (What is infertility?) and was treated with Cetrotide (View Usage). Patient experienced the following unwanted or unexpected effects: heart rate increased, hypertension. Cetrotide dosage: 0.25 Mg, Subcutaneous. During the same period patient was treated with GONAL F (150 Iu) (View Gonal-f Review and Gonal-f Label ).

6278433-0 | Abortion Induced, Ectopic Pregnancy
Patient was taking Cetrotide (View Usage). Patient had the following side effects: abortion induced, ectopic pregnancy on Jul 06, 2009 from KOREA, REPUBLIC OF Additional patient health information: Female patient , 37 years of age, was diagnosed with assisted fertilisation and. Cetrotide dosage: 0.25 Mg, 1 In 1 Days. During the same period patient was treated with PUREGON (FOLLITROPIN BETA) (View Puregon (follitropin Beta) Review and Puregon (follitropin Beta) Label ), MENOTROPINS (View Menotropins Review and Menotropins Label ). Patient was hospitalized.

5836135-6 | Confusional State, Depressed Level Of Consciousness, Diabetes Mellitus, Nausea, Pituitary Tumour Benign, Pyrexia
Adverse event was reported on Jul 21, 2008 by a Female patient taking Cetrotide (View Usage) (Dosage: 1 Dosage Forms, 1 In 1 Days) was diagnosed with in vitro fertilisation, ovarian disorder and. Location: SPAIN , 31 years of age, After Cetrotide was administered, patient had the following side effects: confusional state, depressed level of consciousness, diabetes mellitus, nausea (What is nausea?), pituitary tumour benign, pyrexia. During the same period patient was treated with PERGOVERIS (FIXED COMBINATION OF R HFSH AND R HLH) (View Pergoveris (fixed Combination Of R-hfsh And R-hlh) Review and Pergoveris (fixed Combination Of R-hfsh And R-hlh) Label ). Patient was hospitalized.

5711126-4 | Abdominal Pain, Ascites, Haematocrit Increased, Haemoconcentration, Haemoglobin Increased, Ovarian Hyperstimulation Syndrome, Vomiting, Weight Decreased
on Apr 07, 2008 Female patient from FRANCE , 31 years of age, was diagnosed with in vitro fertilisation and was treated with Cetrotide (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), ascites, haematocrit increased, haemoconcentration, haemoglobin increased, ovarian hyperstimulation syndrome, vomiting, weight decreased. Cetrotide dosage: 0.25 Mg, 1 In 1 Days, Subcutaneous. During the same period patient was treated with CHORIONIC GONADTROPIN (10000 Iu, Intramuscular) (View Chorionic Gonadtropin Review and Chorionic Gonadtropin Label ), PUREGON (FOLLITROPIN BETA) (Subcutaneous) (View Puregon (follitropin Beta) Review and Puregon (follitropin Beta) Label ). Patient was hospitalized.

5572420-3 | Cold Sweat, Dysacusis, Headache, Paraesthesia
on Dec 05, 2007 Female patient from NORWAY , 44 years of age, was treated with Cetrotide (View Usage). Patient had the following side effects: cold sweat, dysacusis, headache (What is headache?), paraesthesia. Cetrotide dosage: 3 Mg, Other. Patient was hospitalized.

5361351-X | Blood Pressure Decreased, Pulmonary Alveolar Haemorrhage
Patient was taking Cetrotide (View Usage). After Cetrotide was administered, patient had the following side effects: blood pressure decreased, pulmonary alveolar haemorrhage on May 30, 2007 from JAPAN Additional patient health information: Female patient , 42 years of age, weighting 108.0 lb, was diagnosed with prevention of premature ovulation, ovulation induction, anaesthesia and. Cetrotide dosage: 0.25 Mg, 1 In 1 Days, Intramuscular. During the same period patient was treated with SEROPHENE (100 Mg, 2 In 1 Days, Oral) (View Serophene Review and Serophene Label ), FERTINORM P (MENOTROPHIN) (75 Mg, Intramuscular) (View Fertinorm P (menotrophin) Review and Fertinorm P (menotrophin) Label ), PREGNYL (10000 Iu, Once) (View Pregnyl Review and Pregnyl Label ), PROPOFOL (150 Mg, Once, Intravenous (not Otherwise Specified)) (View Propofol Review and Propofol Label ), SOSEGON (PENTAZOCINE) (7.5 Mg) (View Sosegon (pentazocine) Review and Sosegon (pentazocine) Label ), PREDONINE (PEDNISOLONE /00016201/) (View Predonine (pednisolone /00016201/) Review and Predonine (pednisolone /00016201/) Label ), BUFFERIN (BUFFERIN /00009201/) (View Bufferin (bufferin /00009201/) Review and Bufferin (bufferin /00009201/) Label ). Patient was hospitalized.

4964569-0 | Allergy Test Positive
Adverse event was reported on Mar 16, 2006 by a Female patient taking Cetrotide (View Usage) (Dosage: 3 Mg, Once, Subcutaneous) was diagnosed with in vitro fertilisation and. Location: FRANCE , 34 years of age, Patient experienced the following unwanted or unexpected effects: allergy test positive. During the same period patient was treated with GONAL F (View Gonal-f Review and Gonal-f Label ), CLOMIPHENE CITRATE (CLOMIPHENE CITRATE) (View Clomiphene Citrate (clomiphene Citrate) Review and Clomiphene Citrate (clomiphene Citrate) Label ). Patient was hospitalized.

4964567-7 | Dizziness, Dyspnoea, Headache, Hypersensitivity, Loss Of Consciousness, Malaise, Paraesthesia
on Mar 16, 2006 Female patient from FRANCE , 34 years of age, was diagnosed with in vitro fertilisation and was treated with Cetrotide (View Usage). Patient had the following side effects: dizziness (What is dizziness?), dyspnoea, headache (What is headache?), hypersensitivity, loss of consciousness, malaise, paraesthesia. Cetrotide dosage: 0.25 Mg, Once, Subcutaneous. During the same period patient was treated with CLOMIPHENE CITRATE (CLOMIFENE) (View Clomiphene Citrate (clomifene) Review and Clomiphene Citrate (clomifene) Label ), RECOMBINANT FSH (FOLLICLE STIMULATING HORMONE, RECOMBINANT) (View Recombinant Fsh (follicle Stimulating Hormone, Recombinant) Review and Recombinant Fsh (follicle Stimulating Hormone, Recombinant) Label ). Patient was hospitalized.

4929510-5 | Dizziness, Headache, Hypersensitivity, Loss Of Consciousness, Malaise, Paraesthesia
on Feb 08, 2006 Female patient from FRANCE , 34 years of age, was diagnosed with in vitro fertilisation and was treated with Cetrotide (View Usage). After Cetrotide was administered, patient had the following side effects: dizziness (What is dizziness?), headache (What is headache?), hypersensitivity, loss of consciousness, malaise, paraesthesia. Cetrotide dosage: 0.25 Mg, Once, Subcutaneous. During the same period patient was treated with CLOMIPHENE CITRATE (CLOMIFENE) (View Clomiphene Citrate (clomifene) Review and Clomiphene Citrate (clomifene) Label ), RECOMBINANT FSH (FOLLICLE STIMULATING HORMONE, RECOMBINANT) (View Recombinant Fsh (follicle Stimulating Hormone, Recombinant) Review and Recombinant Fsh (follicle Stimulating Hormone, Recombinant) Label ). Patient was hospitalized.

4865844-0 | Blood Pressure Decreased, Hypersensitivity, Infusion Site Erythema, Injection Site Vesicles, Tremor
Patient was taking Cetrotide (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, hypersensitivity, infusion site erythema, injection site vesicles, tremor on Dec 02, 2005 from UNITED KINGDOM Additional patient health information: Female patient , 26 years of age, weighting 160.9 lb, was diagnosed with oocyte harvest and. Cetrotide dosage: 0.25 Mg, 1 In 1 Days, Subcutaneous.